WASHINGTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Diagnostic Biomarkers Market finds that because of huge advancement in diagnostic tools, they provide accurate and consistent results at early diagnosis over conventional diagnostic tools. Biomarkers are integrated with high data management technologies and key imaging; thus, it fulfils the need for early diagnosis and meets market expectations. Therefore, it is responsible for augmenting the growth of Diagnostic Biomarkers Market in coming years. The total Global Diagnostic Biomarkers Market is estimated to reach USD 95.1 Billion by 2028.
The market stood at a revenue of USD 45.9 Billion in the year 2021, and expected to grow at a Compound Annual Growth Rate (CAGR) of 12.1%, states Vantage Market Research, in a report, titled “Diagnostic Biomarkers Market by Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.
Please Check Out Our Free Sample Reports and Make a More Informed Decision:
Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/diagnostic-biomarkers-market-1283/request-sample
(Sample reports are a great way to test our in-depth reports or study before you make a purchase)
- The newly updated, 160+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
- Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
- We offer these reports in PDF format so you can read them on your computer and print them out.
- Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
- The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
- Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.
Market Dynamics:
Technological Advancements in Diagnostic Biomarkers Tools Propels the Market Demand
Since from past few years, healthcare industry uses advance technology such as, immunoassays, omics technologies, bioinformatics and diagnostic imaging. In addition, many market leaders are started investing in launching technologically advanced products that provide better patient safety and ease of use. Thus, it increases the demand for biomarkers applications in biomedical industry. In addition, advanced omics technologies provide analysis and identification of mutations & polymorphisms in key genes. Thus, it increases the demand for genomic biomarkers. Due to all these reasons, there is huge demand for Diagnostic Biomarkers Market over the projected time period.
Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/diagnostic-biomarkers-market-1283/1
Benefits of Purchasing Diagnostic Biomarkers Market Reports:
- Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
- Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
- Assured Quality: Focuses on accuracy and quality of reports.
- Incomparable Skills: Analysts provide in-depth insights into reports.
Technical Issues Related to Sample Collection and Storage Hampers the Market Growth
Biomarkers are majorly used in epidemiology studies to identify different types of diseases in humans. For doing this, precious biological samples are required and need to handle & storage carefully. These sample provides large amount of information and reduces future research costs. Therefore, sample collection is the critical task for service providers in terms of handling and storing. In addition, specimen storage, retrieval software and detailed tracking are needed for proper sample management. All these factors are responsible for impeding the growth of Diagnostic Biomarkers Market.
COVID-19 Impact Analysis:
The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the electronics industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:
- Impact Assessment of COVID-19 Pandemic
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
- Key Strategies Undertaken by Companies to Tackle COVID-19
- Long Term Dynamics
- Short Term Dynamics
Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/diagnostic-biomarkers-market-1283
The Report on Diagnostic Biomarkers Market Highlights:
- Assessment of the market
- Premium Insights
- Competitive Landscape
- COVID Impact Analysis
- Historic Data, Estimates and Forecast
- Company Profiles
- Global and Regional Dynamics
Regional Analysis:
North America Accounted Largest Growth of Market
North America is accounted the largest share of the Diagnostic Biomarkers Market during the forecast period. Various growth strategies adopted by key players, large adoption rate of biomarkers for disease diagnostics and increasing use of biomarkers in personalized medicine are augmenting the growth of Diagnostic Biomarkers Market in this region. In addition, rising research studies for the discovery & development of novel biomarkers, increasing adoption of advanced technologies like NGS, increasing use of biomarkers in patient stratification & drug development process and availability of large number of pharmaceutical companies are some other factors that fuels the growth of market in this region.
List of Prominent Players in the Diagnostic Biomarkers Market:
- Biocrates Life Sciences AG
- Augurex Life Sciences Corp.
- Biomedical Corp.
- Target Discovery
- Banyan Biomarkers, Inc.
- Astute Medical, Inc.
- Axela Inc.
Recent Developments:
April, 2021: F. Hoffmann-La Roche Ltd. launched two cardiac biomarker tests for highly sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers support cardiovascular disease management and can help clinicians diagnose heart attacks and manage heart failure better.
May, 2021: QIAGEN N.V. launched the first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit, to identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options in lung cancer.
July, 2020: Thermo Fisher Scientific entered into an agreement with Chugai Pharmaceutical to expand the use of the Oncomine Dx Target Test and expedite local biomarker testing of non-small cell lung cancer (NSCLC) patients eligible for ROZLYTREK (entrectinib) treatment in Japan.
January, 2020: Merck KGaA opened a non-profit, high-tech skill development center in collaboration with the Council of Scientific and Industrial Research’s Institute of Microbial Technology (CSIR-IMTECH) in Chandigarh, India. The center is equipped with genome-editing, single-molecule biomarker detection, and other technologies to help local students build life science skills.
Browse Summary of this Research Report: https://www.vantagemarketresearch.com/blog/diagnostic-biomarkers-814123
Key questions answered in the report:
- Which regional market will show the highest and rapid growth?
- Which are the top five players of the Diagnostic Biomarkers Market?
- How will the Diagnostic Biomarkers Market change in the upcoming six years?
- Which application and product will take a lion’s share of the Diagnostic Biomarkers Market?
- What is the Diagnostic Biomarkers market drivers and restrictions?
- What will be the CAGR and size of the Diagnostic Biomarkers Market throughout the forecast period?
This market titled “Diagnostic Biomarkers Market” will cover exclusive information in terms of Geographic Segmentation, Regional Analysis, Forecast, and Quantitative Date – Units, Key Market Trends, and various others as mentioned below:
| Report Attribute | Details |
| Market Size in 2021 | USD 45.9 Billion |
| Projected Market Size in 2028 | USD 95.1 Billion |
| CAGR Growth Rate | CAGR of 12.1% From 2022 - 2028 |
| Base Year | 2021 |
| Historic Years | 2016 - 2020 |
| Forecast Years | 2022 - 2028 |
| Segments Covered | Disease • Cancer • Cardiovascular Diseases • Neurological Diseases • Immunological Diseases • Others |
| Quantitative Data - Units | Revenue in USD Million/Billion and CAGR from 2022 to 2028 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
| Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
| Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
| Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Download Free Sample Report Now @ https://www.vantagemarketresearch.com/diagnostic-biomarkers-market-1283/request-sample
Browse More Related Report:
- NGS Sample Preparation Market:- https://www.vantagemarketresearch.com/industry-report/ngs-sample-preparation-market-1331
- Autologous Cell Therapy Product Market:- https://www.vantagemarketresearch.com/industry-report/autologous-cell-therapy-product-market-1298
- Single Cell Analysis Market:- https://www.vantagemarketresearch.com/industry-report/single-cell-analysis-market-1295
- 3D Cell Culture Market:- https://www.vantagemarketresearch.com/industry-report/3d-cell-culture-market-1286
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Website: https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
Blog:
- https://bwsc.kr/
- https://makitirapide.com/
- https://www.globalresearchwire.com/
- https://marketstrades.com/
- https://v-mr.biz/
